🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rodrigo Galindo‐Murillo

Ionis Pharmaceuticals (United States)

ORCID: 0000-0001-5847-4143
Biochemistry, Genetics and Molecular BiologyMaterials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Assessing the Current State of Amber Force Field Modifications for DNA─2023 Edition.

N/A
0.635DataRank · unranked
68 citations

Rodrigo Galindo‐Murillo, Marie Zgarbová, Jiřı́ Šponer, Petr Jurečka, Thomas E. Cheatham +1 more

15 citations

Lauren Winkler, Juan Carlos García‐Ramos, Lena Ruíz-Azuara, Fernando Cortés‐Guzmán, Thomas E. Cheatham +1 more

N/A
0.385DataRank · unranked
12 citations

Rodrigo Galindo‐Murillo, Thomas E. Cheatham, Lauren Winkler

140 citations

Thomas E. Cheatham, Rodrigo Galindo‐Murillo

14 citations

Rodrigo Galindo‐Murillo, Daniel R. Roe, Pablo D. Dans, Thomas E. Cheatham, Christina Bergonzo +1 more